Company Profiles

driven by the PitchBook Platform

Pronucleotein Biotechnologies

Pronucleotein Biotechnologies
2005 FOUNDED
M&A STATUS
M&A LATEST DEAL TYPE
Description

Developer of deoxyribonucleic acid aptamer sequences and conjugates. The company's diagnostic platform for development and commercialization of a new food safety testing system can be used at any point in the global food supply chain, and provide results onsite within 30 minutes.

Ownership Status
Acquired/Merged
(Operating Subsidiary)
Financing Status
Corporate Backed or Acquired
Primary Industry
Other Healthcare Services
Other Industries
Other Pharmaceuticals and Biotechnology
Parent Company
CibusDx
Primary Office
4100 North West Loop 410
Suite 230
San Antonio, TX 78229
United States

+1 (210) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Pronucleotein Biotechnologies’s full profile, request a free trial.

Pronucleotein Biotechnologies Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 22-Aug-2017 Completed Generating Revenue
1. Grant 22-Jul-2015 00.00 Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

Pronucleotein Biotechnologies Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
Texas Emerging Technology Fund Venture Capital Minority 000 0000 000000 0

Pronucleotein Biotechnologies Executive Team (4)

Name Title Board
Seat
Contact
Info
John Millice President
John Bruno Ph.D Vice President & Chief Technology Officer
Lynda de la Vina Co-Founder & Director

1 Former Executive

You’re viewing 3 of 4 executives. Get the full list »
Questions or concerns about this profile? Reach out to website-support@pitchbook.com